• Advanced ICU Care transforms ICU performance by leveraging critical care expertise. They provide improved outcomes with measurable results through talented clinicians, supported by leading-edge technology and a commitment to evidence-based best practices and process improvement.

  • Amerita, Inc. is a privately held Specialty Infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost effective delivery settings, a growing bio-pharmaceutical pipeline of infuseable and injectable medications, an aging population and the recent addition of a Medicare benefit for these products and services.

  • Anvita Health™ is an industry-leading health care analytics company that provides caregivers and payers with real-time and batch mode clinical insights to improve outcomes. The Anvita® Insight analysis engine can generate population health insights on millions of members within minutes to hours, enabling daily, continuous dashboards on safety, quality, and gaps-in-care including a 360-degree view of a patient’s medical profile.

  • AtCura is a Southern California company founded in 2012 to empower the person to person connection in the care industry. We are a B2B2C technology company focusing on post-acute care coordination and the long term care needs of the elderly and people with special needs. AtCura established an online platform with an inventory of long term care residential facilities. This is searchable by consumers and health professionals with specific criteria including preferred cultural, social or medical needs. AtCura is dedicated to providing solutions that consistently improve and streamline the industry while also helping the day-to-day lives of those that need care.

  • Avalon Laboratories is the world’s leading supplier of cardiopulmonary vascular cannulae, manufacturing more than three-quarters of all cannulae used globally. In 2008, Avalon produced more than 1.8 million cannulae on a contract basis to the world's leading healthcare suppliers.

  • Biotech Investment group (BIG), founded in 2006, is a provider of growth equity capital to emerging healthcare services companies. BIG is a privately held investment company with significant fund commitments from its founders.

  • Ellipse Technologies, Inc. is focused on developing innovative technologies for state-of-the-art treatments for a broad spectrum of orthopedic deformity uses including broad spinal applications, orthopedic trauma, limb lengthening and genetic diseases.

  • Inogen was founded in 2001 to improve quality of life and increase freedom and independence for oxygen therapy users, predominantly Chronic Obstructive Pulmonary Disease (COPD) patients. COPD is the fourth leading cause of death in the United States, and the only major disease with an ever increasing death rate. By 2020 COPD is predicted to become the third leading cause of death worldwide. COPD affects an estimated 30 million people in the US and over 100 million worldwide.

  • Interventional Spine®, Inc. was founded in February 2000 to solve a key problem confronting surgeons: how to address the aging population and resulting increase of fractures in patients with osteoporotic bone? Fracture fixation devices available at the time had severe limitations when used in the presence of osteoporotic bone. Interventional Spine product development was grounded on the basis of the Company's Compression (CLASP®) technology, which provides effective fixation in both normal and osteoporotic bone. Due to the superior fracture fixation characteristics of the CLASP® technology, Interventional Spine originally designed devices for the Podiatric and Orthopedic Trauma markets, successfully implanting over 4,000 Orthopedic Trauma Products in patients.

  • InTouch Health provides telehealth services to healthcare organizations to deliver high-quality virtual care, anytime, anywhere.

  • Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery. But each of these has its limitations. Glaucoma remains the leading cause of blindness worldwide, in need of better treatment alternatives. It is our goal to develop new and effective solutions for ophthalmology specialists and the 70 million people worldwide who are affected by this debilitating and sight-stealing disease.

  • Newport Corporation (Nasdaq: NEWP) is a leading global supplier of advanced technology products and solutions for Scientific Research, Life & Health Science, Aerospace & Defense, Photovoltaics, Industrial Manufacturing, Semiconductors, and Microelectronics markets.

  • Pathway Diagnostics Ltd was established in 2000 as a manufacturing and consulting company specialising in the field of haemostasis.

  • Silicon Valley Medical Instruments, Inc. delivers products that combine vision, elegance and simplicity to reduce procedural time, increase interventional confidence and improve patient outcomes.

  • TherOx, Inc. is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients.